Cryoport, Inc. (CYRX) — 10-Q Filings

10-Q Filings (6)

• Cryoport Swings to Profit on Strategic Divestiture, Revenue Up 13% — Nov 6, 2025 Risk: medium
  Cryoport, Inc. (CYRX) reported a significant turnaround in net income for the nine months ended September 30, 2025, reaching $89.945 million, a substantial impr
• Cryoport Navigates Q2 with Equity Shifts and Diversified Investments — Aug 12, 2025 Risk: medium
  Cryoport, Inc. (CYRX) filed its 10-Q for the quarter ended June 30, 2025, showing a continued focus on its life sciences logistics. While specific revenue and n
• Cryoport, Inc. Files Q1 2025 10-Q — May 8, 2025 Risk: low
  Cryoport, Inc. filed its 10-Q for the period ending March 31, 2025. The company, operating in the Pharmaceutical Preparations sector, reported on its financial
• Cryoport, Inc. Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Cryoport, Inc. filed its 10-Q for the period ending September 30, 2024. The company, operating in pharmaceutical preparations, reported financial results for th
• Cryoport, Inc. Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Cryoport, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position. Key financial data point
• Cryoport, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
  Cryoport, Inc. (CYRX) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Cryoport, Inc. filed a 10-Q report for the period ending March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX